-
The team of Professor Ye Dingwei from the Cancer Hospital of Fudan University and the team of Professor Huang Haojie from Mayo Clinic in the United States have discovered potential new targets for precision treatment of prostate cancer
Time of Update: 2021-11-16
For many years, the Multidisciplinary Urology and Oncology (MDT) team of Fudan University Cancer Hospital, led by the chief expert Professor Ye Dingwei, has addressed the "three dilemmas" of the low early diagnosis rate of Chinese prostate cancer, the low late survival rate and the lack of effective precision treatment models.
-
Women are more likely to get thyroid cancer?
Time of Update: 2021-11-16
This study analyzed the incidence and mortality data of major thyroid cancer histological types and tumor size categories for women and men in the United States, and conducted a meta-analysis by gender to investigate the prevalence of subclinical thyroid cancer in the total thyroid outcome .
-
The survival period is expected to be extended by nearly 1 year! Don't forget to do this after you have lung cancer
Time of Update: 2021-11-16
According to a study published in Chest, the official journal of the American College of Physicians (ACCP), people who quit smoking after a diagnosis of non-small cell lung cancer (NSCLC) prolonged their lifespan by nearly one year compared to those who continued to smoke .
-
Hengrui's postoperative analgesia combination therapy was approved for clinical use
Time of Update: 2021-11-16
Article source: Medical Rubik's Cube InfoOn October 21, the CDE official website showed that the clinical trial application of Hengrui SHR8554 combined with SHR0410 for the treatment of postoperative acute moderate to severe pain was approved by the China Food and Drug Administration .
The clinical application of SHR8554 monotherapy for postoperative pain has advanced to Phase II/III .
-
Hui Jingyi's group collaborated to reveal the dissociation and functional mechanism of MeCP2/Rbfox/LASR protein super-large complex in mice with Rett syndrome
Time of Update: 2021-11-16
It is reported that MeCP2 has a functional mechanism that regulates mRNA splicing through phase separation and assembly of large protein complexes, and is the cause of Rett syndrome.
-
The latest clinical research protocol of carrelizumab and apatinib mesylate combined with vascular interventional treatment of unresectable solid tumors will be featured in the 2021 ESMO poster
Time of Update: 2021-11-16
Anti-angiogenic drugs combined with immunotherapy can reshape the tumor immunosuppressive microenvironmentAccording to Professor Gao Feng, the principal investigator of the study and the chief physician of the Third Department of Oncology, Peking Dahuang Group General Hospital, “On the one hand, immunotherapy represented by vascular interventional therapy combined with immune checkpoint inhibitors has a synergistic effect in activating immune function .
-
Pepaxto withdraws from the US market: Phase 3 clinical failure in the treatment of multiple myeloma
Time of Update: 2021-11-16
The reason is: the phase 3 OCEAN study failed, and the results showed that: in the intention-to-treat (ITT) patient group, the overall survival hazard ratio (HR) was 1.
-
Merck/Seagen launches phase 3 clinical treatment of breast cancer with HER2 small molecule inhibitor in China
Time of Update: 2021-11-16
Text|Pharmaceutical Mission HillsOn October 18, the Chinese drug clinical trial registration and information disclosure platform showed that Merck (MSD) and Seagen have launched a phase 3 clinical trial of tucatinib in China for the treatment of locally advanced or metastatic HER2-positive breast cancer .
-
The college went to Xiantao to promote the "Rural Revitalization Jingchu Tour"
Time of Update: 2021-11-16
Nanhu News Network (correspondent Du Ruiyao Zhou Yan) On October 21, Professor Bian Yinbing from the Institute of Applied Mycology of the Institute of Plant Science and Technology led a team to Xiantao Village, Zhanggou Town, Xiantao City to carry out "Stropharia stropharia (Red Matsutake)" for local villagers.
-
"Breathing to test the new crown" becomes possible
Time of Update: 2021-11-16
A paper recently published online in the international academic journal "Journal of Respiratory Research" shows that the team of Professor Maosheng from the School of Environment of Peking University cooperated with teams such as the Chaoyang District Center for Disease Control and Prevention of Beijing to integrate exhaled breath sampling, gas chromatography-ion migration Spectral detection and machine learning models have developed a non-invasive exhaled breath volatile organic compound fingerprint screening system for COVID-19 infection.
-
Josip Heit's comment on the current state of coronavirus management
Time of Update: 2021-11-16
Therefore, logically, given the current vaccination rates in the German states, the epidemic can be used as a nationwide exemption.
Therefore, German companies are transitioning from an emergency state to a particularly cautious state, although it is hoped that according to the current situation, it may enter a normal state next spring .
-
The application for phase III clinical trial of HER2 double antibody KN026 was officially accepted by CDE
Time of Update: 2021-11-16
HK) jointly announced the recombinant humanized anti-HER2 bispecific A phase III clinical trial application of the sex antibody KN026 (study number: KN026-306) was formally accepted by CDE, and the registration clinical study of combined chemotherapy for advanced gastric cancer/gastroesophageal junction adenocarcinoma with disease progression after first-line standard chemotherapy will be carried out .
-
In vivo gene editing achieves another breakthrough, first children's clinical results released
Time of Update: 2021-11-16
The design of LB-001 uses an AAV vector to precisely insert a transgene expressing methylmalonyl-CoA mutase (MMUT) into the albumin gene locus of liver cells .
-
U.S. FDA approves Gilead's low-dose Biktarvy for use in young HIV-1 children
Time of Update: 2021-11-16
Fovir, BIC/FTC/TAF, 30mg/120mg/15mg, low-dose tablets), used for a body weight of at least 14 kg to 25 kg, has achieved virological suppression, or has just started receiving antiretroviral drugs (ARV) Treated children with HIV-1 infection .
-
[Website of Hubei Provincial Department of Agriculture and Rural Affairs] Hubei launched the provincial local standard "Cotton no-tillage live planting...
Time of Update: 2021-11-16
Under the guidance of the Provincial Department of Agriculture and Rural Affairs, the Provincial Market Supervision Administration, and Huazhong Agricultural University, in order to give full play to
-
448 million dollars!
Time of Update: 2021-11-16
According to the agreement, Lingbei obtained the global exclusive rights to the research, development and commercialization of the latter's neuroimmune disease candidate drug APB-A1, which is a new and well-differentiated anti-CD40 ligand (CD40L) Antibody-like drug candidates are expected to undergo phase 1 clinical trials around the beginning of 2022 .
-
One-time drug suppression of HIV for up to six months, Elite Neutralizing Antibody Phase 1 Trial Published
Time of Update: 2021-11-16
A phase 1 trial recently published by "Nature-Medical" initially showed that PGT121 is safe and shows good antiviral activity in HIV-1 infected persons, and has achieved long-term viral suppression for nearly half a year in individual patients .
-
The Zhang Weishe team of Xiangya Hospital first discovered the missing disease-causing gene in both kidneys
Time of Update: 2021-11-16
Therefore, NPNT is considered to be a possible pathogenic gene for the absence of both kidneys, but previous studies have not reported NPNT mutations in patients with renal hypoplasia .
-
Research by He Qiang's team from Fudan University reveals the effectiveness of biological invasion in reducing coastal wetland protected areas
Time of Update: 2021-11-16
The main nature reserves in the Yellow Sea and Bohai Sea in China have slowed down wetland reclamation, but have suffered more intense invasion by exotic plantsAfter the invasion of Spartina alterniflora, a large area of key waterfowl habitat in the protected area became a "green desert" unsuitable for waterfowl habitation.
-
The disappearance of Morro Bay seagrass leads to changes in fish populations
Time of Update: 2021-11-16
Walter, O'Leary, and other researchers at the California Institute of Technology, in collaboration with the Morro Bay National Estuary Program, continue to study the causes and consequences of the decline in the number of leaf algae .
